Effects produced by automated plasmapheresis on morphofunctional data on cardiovascular system performance in ischemic heart disease patients

Автор: Malchevsky Yury E., Ragimov Aligeidar A.

Журнал: Cardiometry @cardiometry

Рубрика: Original research

Статья в выпуске: 16, 2020 года.

Бесплатный доступ

We have performed the study of the effects made by the automated plasmapheresis application on ischemic heart disease clinical manifestations, echocardiographic indices and heart rate variability in patients with exertional angina III-IV functional class. It has been found that the applied plasmapheresis method is capable to reduce the severity of the disease clinical manifestations and improve the echocardiographic characteristics of the heart, in particular, reduce the level of end-diastolic volume, and increase ejection fraction. The clinical effect is already apparent at the early stages of the treatment and remains unchanged even after 6 months thereof. Also revealed has been the normalization of heart rate variability, indicating a decreased activity of the sympathetic nervous system. It is concluded that the plasmapheresis method can be successfully used in practice by a wide range of hospitals, where patients with ischemic heart disease are monitored, including the ambulatory conditions.

Еще

Exertional angina, plasmapheresis, echocardiography, heart rate variability, holter monitoring

Короткий адрес: https://sciup.org/148311460

IDR: 148311460   |   DOI: 10.12710/cardiometry.2020.16.117122

Список литературы Effects produced by automated plasmapheresis on morphofunctional data on cardiovascular system performance in ischemic heart disease patients

  • Voinov VA. Plasmapheresis in antiphospholip¬id syndrome. Efferent and physico-chemical medi-cine.2012;1:47–50. [in Russian]
  • Oganov RG, Maslennikova GY. Demographic trends in the Russian Federation: the contribution of diseases of the circulatory system. Cardiovascular therapy and prevention. 2012; 1: 5-10. [in Russian]
  • Petukhov EV, Konovalov GA, Barinov V. Rheoph¬eresis value in the treatment of patients with athero-sclerosis. XIV Conference of the Moscow City Society hemopheresis "Transfusion and detoxification therapy in case of emergency." M., 2006, pp 33-34. [in Russian]
  • Postnikov AA, Model SV, Bozhyev AA, et al. Coagu¬lation and rheological mechanisms of therapeutic effi¬cacy of plasmapheresis in patients with coronary heart disease. Mat. First All-Russian scientific. conf. "Clin¬ical Hemostasis and hemorheology in cardiovascular surgery." Moscow, 2003. p. 75 [in Russian]
  • Andrulli S, Bigi MC, Granata A, et al. Therapeutic plasma exchange: a review of the literature. G. Ital. Nefrol. 2012;29(54):40-8.
  • Baskurt OK. In vivo correlates of altered blood rhe¬ology. Biorheology. 2008;45(6):629-38.
  • Chin SP, Jeyaindran S, Azhari R, et al. Acute coro¬nary syndrome (ACS) registry-leading the charge for National Cardiovascular Disease (NCVD) Database. Med. J. Malaysia. 2008;63:29-36.
  • Filipovic N, Ravnic D, Kojic M. et al. Interactions of blood cell constituents: experimental investigation and computational modeling by discrete particle dynamics algorithm. Microvasc. Res. 2008;75(2):279-84.
  • Leschke M. Rheology and coronary heart disease. Dtsch. Med. Wochenschr. 2008;133(8):270-3.
  • Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation. 2002;105:1135–43.
  • Mancini E, Santoro A. Plasmapheresis in intensive care. G. Ital. Nefrol. 2012;29(54):91-102.
  • Ridker PM. Inflammatory biomarkers and risks of myocardial infarction, stroke, diabetes, and to¬tal mortality: implications for longevity. Nutr. Rev. 2007;65(12):253–9.
Еще
Статья научная